Please assess the completion status of the following clinical trial:

Trial Title: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is diagnosed with bipolar I disorder, most resent episode depressed~* Subject must have a lifetime history of at least one bipolar manic or mixed episode~* Subject must be taking lithium or divalproex at least 28 days prior to screening~Exclusion Criteria:~* History of nonresponse to an adequate (6-week) trial of three or more antidepressants (with or without mood stabilizers) during the current episode~* Subject has been hospitalized for a manic or mixed episode within 60 days prior to randomization~* Imminent risk of suicide or injury to self, others, or property

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Lurasidone (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).